Certified by Founder Lodge
Matchpoint Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 17 ,2022 | Series A | $100,000,000 |
Access Industries
Sanofi
Atlas Venture
Vertex Ventures HC
Digitalis Ventures
Alexandria Real Estate Equities, Inc.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
TRIANA Biomedicines | $120,000,000 | (Dec 4, 2025)
Ridley | $6,400,000 | (Dec 4, 2025)
Autolane | $7,400,000 | (Dec 4, 2025)
Juniper Biosciences | $40,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)